Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
11 studies found for:    elvucitabine
Show Display Options
Rank Status Study
1 Completed Comparison of Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects
Condition: HIV Infections
Interventions: Drug: elvucitabine;   Drug: Lamivudine;   Drug: Tenofovir;   Drug: Efavirenz
2 Completed An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment
Condition: HIV Infections
Intervention: Drug: elvucitabine
3 Completed Open-Label, 48 Week Extension Study of Elvucitabine in Combination With Background ART For Subjects Who Have Completed Study ACH443-014A
Condition: HIV-1 Infection
Interventions: Drug: elvucitabine;   Drug: Lamivudine;   Drug: Emtricitabine
4 Completed Study of Once Daily Elvucitabine Versus Lamivudine in Subjects With a Documented M184V Mutation
Condition: HIV Infections
Interventions: Drug: elvucitabine;   Drug: Lamivudine
5 Terminated Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIs
Conditions: HIV Infections;   Human Immunodeficiency Virus
Intervention: Drug: Dexelvucitabine
6 Completed Safety Study of Elvucitabine in HIV-1 Subjects
Condition: HIV Infections
Intervention: Drug: elvucitabine
7 Completed A Study of DPC 817 in HIV-Infected Males
Condition: HIV Infections
Intervention: Drug: DPC 817
8 Terminated Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: ACH126, 433 (b-L-Fd4C)
9 Completed Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment Naive Adults With Chronic Hepatitis B Virus Infection
Condition: Hepatitis B, Chronic
Interventions: Drug: ACH-126, 443 (beta-L-Fd4C);   Drug: Lamivudine;   Drug: Placebo
10 Terminated Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.
Condition: Chronic Hepatitis B
Intervention: Drug: ACH-126, 443 (beta-L-Fd4C)
11 Terminated Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.
Condition: HIV Infections
Intervention: Drug: ACH126-443 (Beta-L-Fd4C)

Indicates status has not been verified in more than two years